Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications

Expert Review of Anti-Infective Therapy

Volumn 15, Issue 7, 2017, Pages 713-721

  Nakwatumbah, S ^a   Kibuule, D ^a   Godman, B ^b,c   Haakuria, V ^a   Kalemeera, F ^a   Baker, A ^c   Mubita, M ^a  

^a UNIVERSITY OF NAMIBIA   (Namibia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

ambulatory care; Antibiotics; guideline compliance; Namibia; predictors; prescribing patterns

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH INFECTION; NAMIBIA; PHYSICIAN ATTITUDE; PILOT STUDY; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; PROTOCOL COMPLIANCE; QUESTIONNAIRE; SYMPTOM; TOOTH INFECTION; UPPER RESPIRATORY TRACT INFECTION; UROGENITAL TRACT INFECTION; BACTERIAL INFECTION; PATIENT REFERRAL; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; GUIDELINE ADHERENCE; HUMANS; NAMIBIA; PILOT PROJECTS; PRACTICE PATTERNS, PHYSICIANS'; REFERRAL AND CONSULTATION;

EID: 85018332477     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1080/14787210.2017.1320220     Document Type: Article

References (67)

1. Wanyiri JW, Kanyi H, Maina S, et al. O’Connor R Infectious diarrhoea in antiretroviral therapy-naive HIV/AIDS patients in Kenya. Trans R Soc Trop Med Hyg. 2013;107(10):631–638.
2. Avdeeva O, Lazarus JV, Aziz MA, et al. The global fund’s resource allocation decisions for HIV programmes:addressing those in need. J Int AIDS Soc. 2011 Oct 26;14:51.
3. Laing R, Waning B, Gray A, et al. 25 years of the WHO essential medicines lists:progress and challenges. Lancet. 2003;361(9370):1723–1729.
4. Donkor ES, Tetteh-Quarcoo PB, Nartey P, et al. Self-medication practices with antibiotics among tertiary level students in Accra, Ghana:A cross-sectional study. Int J Environ Res Public Health. 2012;9(10):3519–3529.
5. Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
6. Kibuule D, Kagoya HR, Godman B., Antibiotic use in acute respiratory infections in under-fives in Uganda:findings and implications. Expert Rev Anti Infect Ther. 2016;14(9):863–872.
7. Morgan DJ, Okeke IN, Laxminarayan R, et al. Non-prescription antimicrobial use worldwide:A systematic review. Lancet Infect Dis. 2011;11(9):692–701.
8. Center for Disease Dynamics, Economics & Policy. State of the world’s antibiotics, 2015. Washington, D.C:CDDEP; 2015. Available at https://cddep.org/sites/default/files/swa_2015_final.pdf
9. Heather F, Versporten A, Whitelaw A, et al. The global point prevalence survey of antimicrobial consumption and resistance (Global-PPS):results of antimicrobial prescribing in a south African tertiary hospital. Available at:http://www.global-pps.com/wp-content/uploads/ECCMID-2016_South-Africa.pdf
10. Reardon S, Dramatic rise seen in antibiotic use. Available at:https://doi.org/10.1038/nature.2015.18383
11. Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010:an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750.
12. Massele A, Burger J, Katende-Kyenda NL, et al. Outcome of the first medicines utilization research in Africa group meeting to promote sustainable and rational medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885–888.
13. Marseille E, Hofmann PB, Kahn JG., HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002;359(9320):1851–1856.
14. Dyar OJ, Beovic B, Vlahovic-Palcevski V, et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016;14(4):403–413.•• The paper highlights interventions that can be implemented in ambulatory care to reduce antibiotic prescribing.
15. de-Graft Aikins A, Unwin N, Agyemang C, et al. Tackling Africa’s chronic disease burden:from the local to the global. Global Health. 2010;6:5.
16. HM Government. Antimicrobial Resistance:tackling a crisis for the health and wealth of nations. Available via:https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf
17. Kimang’a AN. A situational analysis of antimicrobial drug resistance in Africa:are we losing the battle? Ethiop J Health Sci. 2012;22(2):135–143. Available from:https://doi.org/10.4314/ejhs.v22i2•• Describes the historical perspective of penicillins in Africa, their oversue and the development of resistance. Several multiple interventions are suggested to improve future antibiotic use.
18. Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing:a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680.• Reviews a number of key issues regarding physician prescribing of antibiotics and potential ways forward including greater physician education.
19. Shallcross LJ, Davies SC. The world health assembly resolution on antimicrobial resistance. J Antimicrob Chemother. 2014;69(11):2883–2885.
20. World Health Organization. Antimicrobial resistance:global report on surveillance. Available at:http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1
21. World Health Organization. Worldwide country situation analysis:response to antimicrobial resistance. Available from:http://www.who.int/drugresistance/documents/situationanalysis/en/
22. Iileka AEK, Mukesi M, Engelbrecht F, et al. Antimicrobial susceptibility patterns of staphylococcus aureus strains isolated at the Namibia institute of pathology from 2012 to 2014. Open J Med Microbiol. 2016;6:116–124.
23. Mengistu A, Gaeseb J, Uaaka G, et al. Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia:implications for empirical antibiotic treatment of meningitis. J Pharm Policy Pract. 2013 Jun 13;6:4.
24. Akpabio E, Sagwa E, Mazibuko G, et al. Assessment of compliance of outpatient prescribing with the Namibia standard treatment guidelines in public sector health facilities. Windhoek. 2014. Available from http://apps.who.int/medicinedocs/documents/s21715en/s21715en.pdf•• This paper shows that despite the implementation of guidelines, adherence to the guidelines in Namibia remains sub-optimal among the prescribers.
25. Ministry of Health and Social Services. National Pharmacy Management Information Systems (PMIS) Feedback report Apr. Windhoek; 2015 Sep.
26. Pereko DD, Lubbe MS, Essack SY. Antibiotic use in Namibia:prescriber practices for common community infections. South Afr Fam Pract. 2015;57(4):231–235. Available from:https://doi.org/10.1080/20786190.2015.1024021
27. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8(3):278–282.
28. Goossens H, Ferech M, Vander Stichele R, et al. ESAC project group. Outpatient antibiotic use in Europe and association with resistance:A cross-national database study. Lancet. 2005;365(9459):579–587.
29. Gyssens I. Antibiotic Policy. Int J Antimicrob Agents. 2011;38S:11–20.
30. Linder JA, Stafford RS. Antibiotic treatment of adults by community primary care physicians:national survey, 1989-1999. Jama. 2001;286(10):1181–1186.
31. Mazur E. Rational antibiotic therapy of acute upper respiratory tract infections. Polski Merkuriusz Lekarski. 2010;29(173):304–308.• Highlights the importance of interventions to control the prescribing of antibiotics in acute respiratory infections and suggests mechanisms to promote rational therapy in several upper respiratory infections.
32. Riedel S, Beekmann SE, Heilmann KP, et al. Antimicrobial use in Europe and antimicrobial resistance in streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2007;26(7):485–490.
33. Sumpradit N, Chongtrakul P, Anuwong K, et al. Butdeemee P etal. antibiotics Smart use:a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ. 2012;90(12):905–913.
34. Llor C, Bjerrum L. Antimicrobial resistance:risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic Advances Drug Safety. 2014;5(6):229–241.•• Highlights key target areas for implementing multifaceted interventions to control antibiotic overuse and reduce antimicrobial resistance.
35. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. Jama. 2016;315(17):1864–1873.
36. Adorka M, Honoré MK, Lubbe M, et al. The impact of appropriate antibiotic prescribing on treatment evaluation parameters. J Public Health Africa. 2013;4(1):2.
37. Al-Niemat SI, Bloukh DT, Al-Harasis MD, et al. Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators. Saudi Med J. 2008;29(5):743–748.
38. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care:prospective study in 13 countries. Bmj. 2009;338:b2242.
39. Osatakul S, Puetpaiboon A. Appropriate use of antibiotics in acute diarrhoae:a cross sectional survey in southern Thailand. Ann Trop Paediatr. 2007;27(2):115–122.
40. Akkerman AE, Van Der Wouden JC, Kuyvenhoven MM, et al. Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother. 2004;54(6):1116–1121.
41. Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections:retrospective cohort study with the UK general practice research database. Bmj. 2007;335(7627):982.
42. Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. Bmj. 2003;326(7381):138.
43. Adriaenssens N, Coenen S, Tonkin-Crine S, et al. European Surveillance of Antimicrobial Consumption (ESAC):disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Quality & Safety. 2011.• This paper proposes indicators for monitoring antibiotic use in outpatient departments which can be extrapolated or adapted for monitoring antibiotic use in OPD settings in Africa.
44. Kunda M. An investigation of antibiotic prescribing in patients with upper respiratory tract infections (URTIs) at Katutura Health Centre. University of Namibia. 2014. Available from http://repository.unam.na/handle/11070/843
45. Ministry of Health and Social Services. Namibia Standard Treatment Guidelines. First Edition, Windhoek; MoHSS. 2011. Available from http://apps.who.int/medicinedocs/documents/s19260en/s19260en.pdf
46. Matowe L, Waako P, Adome RO, et al. A strategy to improve skills in pharmaceutical supply management in East Africa:the regional technical resource collaboration for pharmaceutical management. Hum Resour Health. 2008;6:30.
47. Waako PJ, Odoi-Adome R, Obua C, et al. Existing capacity to manage pharmaceuticals and related commodities in East Africa:an assessment with specific reference to antiretroviral therapy. Hum Resour Health. 2009;7:21.
48. Teixeira Rodrigues A, Ferreira M, Pineiro-Lamas M, et al. Determinants of physician antibiotic prescribing behavior:a 3 year cohort study in Portugal. Curr Med Res Opin. 2016;32(5):949–957.
49. O’Keefe RM. Investigating outpatient departments:implementable policies and qualitative approaches. J Oper Res Soc. 1985;36(8):705–712. Available from:https://doi.org/10.1057/jors.1985.12
50. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients:systematic review and meta-analysis. Bmj. 2010;340:c2096.
51. Steinke DT, Bain DJ, MacDonald TM, et al. Practice factors that influence antibiotic prescribing in general practice in Tayside. J Antimicrob Chemother. 2000;46(3):509–512.
52. Ministry of Health and Social Services. Namibia Pharmaceutical Management Information System (PMIS) Manual. Windhoek.
53. Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol. 2006;62(5):373–379.
54. Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings:a systematic review. Infection Control and Hospital Epidemiology. 2015;36(2):142–152.
55. World Health Organization. How to investigate drug use in health facilities:selected drug use indicators. Available at:http://www.who.int/medicines/publications/how-to-investigate_drug-use/en/
56. World Health Organization. Introduction to drug utilization research World Health Organization WHO international working group for drug statistics methodology. Available at:http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf
57. Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region:a systematic analysis (1995-2015). BMC Public Health. 2016;16:724.
58. Kallander K, Burgess DH, Qazi SA. Early identification and treatment of pneumonia:a call to action. The Lancet Global Health. 2016;4(1):e12–3.
59. Williams BG, Gouws E, Boschi-Pinto C, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2(1):25–32.
60. World Health Organization. Namibia:WHO Statistical Profile. Available from:http://www.who.int/gho/countries/nam.pdf?ua=1
61. Adorka M, Mitonga HK, Allen K, et al. Assessing the effectiveness of Empiric Aantibiotic treatments:the use of an antibiogram based methodology in the case of selected public hospitals in lesotho. J Pharm Care. 2014;2(3):85–95.
62. Royal College of Pathologists. An audit of antimicrobial stewardship “Start Smart - then Focus” compliance with national and local recommendations for antimicrobial prescribing. Available from:https://www.rcpath.org/resourceLibrary/an-audit-of-antimicrobial-stewardship-start-smart-then-focus-compliance-with-national-and-local-recommendations-for-antimicrobial-prescribing.html
63. Chowdhury AK, Khan OF, Matin MA, et al. Effect of standard treatment guidelines with or without prescription audit on prescribing for acute respiratory tract infection (ARI) and diarrhoea in some thana health complexes (THCs) of Bangladesh. Bangladesh Med Res Counc Bull. 2007;33(1):21–30.
64. Kibuule D, Mubita M, Naikaku E, et al. An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia’s public sector:findings and therapeutic implications. Int J Clin Pract. 2017; Feb;71(2).• This study highlights the policy gaps for promoting the rational use of antibiotics and suggests additional indicators for the effective monitoring antibiotic use along side the WHO indicators.
65. Sabuncu E, David J, Bernede-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. Plos Medicine. 2009;6(6):e1000084.
66. Furst J, Cizman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade:findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289.
67. Godman B, Fadare J, Kibuule D, et al. Initiatives across countries to reduce antibiotic utilization and resistance patterns; impact and implications. 2017:539–576. in Drug Resistance in Bacteria, Fungi, Malaria, and Cancer - Arora, Sajid, & Kalia Eds. Publisher Springer Nature. ISBN 978-3-319-48682-6. Available at http://www.springer.com/us/book/9783319486826#• This book chapter underscores the importance of collaborative efforts to enhance the appropriate use of antibiotics in African countries as well as discussing potential strategies to improve antibiotic use.